• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者发生肝细胞癌的危险因素:613例患者的前瞻性研究

Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients.

作者信息

Zaman S N, Melia W M, Johnson R D, Portmann B C, Johnson P J, Williams R

出版信息

Lancet. 1985 Jun 15;1(8442):1357-60. doi: 10.1016/s0140-6736(85)91785-4.

DOI:10.1016/s0140-6736(85)91785-4
PMID:2861313
Abstract

In a prospective study of 613 patients with cirrhosis of different aetiological types increasing age, male sex, and non-UK nationality were found to be significant independent risk factors for the progression of cirrhosis to hepatocellular carcinoma. Seropositivity for hepatitis B surface antigen and the duration and aetiology of cirrhosis were not related to the development of the disease. Age and sex were also found to be significant risk factors when UK patients alone were considered. Seropositivity for hepatitis B surface antigen may be associated with hepatocellular carcinoma only because hepatitis B virus infection is a common cause of cirrhosis.

摘要

在一项针对613例不同病因类型肝硬化患者的前瞻性研究中,发现年龄增长、男性以及非英国国籍是肝硬化进展为肝细胞癌的重要独立危险因素。乙肝表面抗原血清阳性以及肝硬化的病程和病因与该疾病的发生无关。仅考虑英国患者时,年龄和性别也是重要的危险因素。乙肝表面抗原血清阳性可能仅因为乙肝病毒感染是肝硬化的常见病因而与肝细胞癌相关。

相似文献

1
Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients.肝硬化患者发生肝细胞癌的危险因素:613例患者的前瞻性研究
Lancet. 1985 Jun 15;1(8442):1357-60. doi: 10.1016/s0140-6736(85)91785-4.
2
Risk factors of hepatocellular carcinoma in Germany: hepatitis B or liver cirrhosis?德国肝细胞癌的危险因素:乙型肝炎还是肝硬化?
Hepatogastroenterology. 1988 Aug;35(4):151-7.
3
Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in south India--an autopsy study.印度南部的乙肝表面抗原、肝细胞癌和肝硬化——一项尸检研究
Indian J Pathol Microbiol. 1990 Oct;33(4):334-8.
4
Hepatocellular carcinoma in white South Africans--aetiological considerations.南非白人中的肝细胞癌——病因学考量
S Afr Med J. 1984 Dec 1;66(22):835-7.
5
Epidemiology of hepatocellular carcinoma.肝细胞癌的流行病学
Gastroenterol Clin North Am. 1987 Dec;16(4):545-51.
6
An appraisal of the relationship between primary hepatocellular carcinoma and hepatitis B virus.原发性肝细胞癌与乙型肝炎病毒之间关系的评估
Histopathology. 1979 Nov;3(6):447-58. doi: 10.1111/j.1365-2559.1979.tb03027.x.
7
Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis.967例肝硬化患者肝细胞癌的发病率及危险因素
J Cancer Res Clin Oncol. 1998;124(10):560-4. doi: 10.1007/s004320050215.
8
[Relationship between hepatocellular carcinoma, liver cirrhosis and hepatitis B: a pathological study].[肝细胞癌、肝硬化与乙型肝炎之间的关系:一项病理学研究]
Zhonghua Yi Xue Za Zhi. 1982 May;62(5):257-61.
9
Risk factors for hepatocellular carcinoma.肝细胞癌的危险因素。
Lancet. 1985 Sep 7;2(8454):552-3. doi: 10.1016/s0140-6736(85)90486-6.
10
Hepatitis B virus, hepatocellular carcinoma and liver cirrhosis in Kenya.肯尼亚的乙型肝炎病毒、肝细胞癌和肝硬化
East Afr Med J. 1993 Apr;70(4 Suppl):34-6.

引用本文的文献

1
Regulation of MYO18B mRNA by a network of C19MC miRNA-520G, IFN-γ, CEBPB, p53 and bFGF in hepatocellular carcinoma.C19MC miRNA-520G、IFN-γ、CEBPB、p53 和 bFGF 调控网络对肝癌中 MYO18B mRNA 的调控。
Sci Rep. 2020 Jul 23;10(1):12371. doi: 10.1038/s41598-020-69179-5.
2
Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus.索非布韦/利巴韦林治疗日本 2 型丙型肝炎病毒时,肝癌或干扰素治疗史会减弱疗效。
World J Gastroenterol. 2018 Apr 7;24(13):1478-1485. doi: 10.3748/wjg.v24.i13.1478.
3
Diabetes Mellitus and Risk of Hepatocellular Carcinoma.
糖尿病与肝细胞癌风险。
Biomed Res Int. 2017;2017:5202684. doi: 10.1155/2017/5202684. Epub 2017 Dec 12.
4
Influence of polymorphisms in the Wnt/β-catenin pathway genes on hepatocellular carcinoma risk in a Chinese Han population.Wnt/β-连环蛋白通路基因多态性对中国汉族人群肝细胞癌风险的影响
Medicine (Baltimore). 2017 Mar;96(12):e6127. doi: 10.1097/MD.0000000000006127.
5
Unusual Presentation of Hepatocellular Carcinoma into Right iliac fossa: A Rare Entity.肝细胞癌罕见地表现于右髂窝:一种罕见情况。
J Clin Diagn Res. 2015 Nov;9(11):PD11-2. doi: 10.7860/JCDR/2015/14627.6805. Epub 2015 Nov 1.
6
Liver transplantation as a management of hepatocellular carcinoma.肝移植作为肝细胞癌的一种治疗手段。
World J Hepatol. 2015 Jun 8;7(10):1347-54. doi: 10.4254/wjh.v7.i10.1347.
7
Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis.原发性胆汁性肝硬化患者发生肝细胞癌的发病率及危险因素。
Clin Rev Allergy Immunol. 2015 Jun;48(2-3):132-41. doi: 10.1007/s12016-015-8483-x.
8
Impact of PIVKA-II in diagnosis of hepatocellular carcinoma.异常凝血酶原在肝细胞癌诊断中的作用。
J Adv Res. 2013 Nov;4(6):539-46. doi: 10.1016/j.jare.2012.10.004. Epub 2013 Jan 11.
9
Validation of Bmi1 as a therapeutic target of hepatocellular carcinoma in mice.验证Bmi1作为小鼠肝细胞癌治疗靶点的作用
Int J Mol Sci. 2014 Nov 3;15(11):20004-21. doi: 10.3390/ijms151120004.
10
Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors?活体供肝肝移植治疗肝细胞癌:一切都与供体有关吗?
Int J Organ Transplant Med. 2013;4(4):137-43.